In this second installment of MedPage Today's virtual roundtable series on pediatric low-grade glioma, moderator Jason Fangusaro, MD, of Emory University School of Medicine in Atlanta, is joined once ...

These tumors are less likely to spread to surrounding tissues than higher-grade tumors, so they often have better outcomes. In the past, pediatric gliomas were classified into low-grade and high-grade ...

MedPage Today brought together three expert leaders for a virtual roundtable discussion on pediatric low-grade glioma. Moderator Jason Fangusaro, MD, of Emory University School of Medicine in Atlanta, ...

Phase II Trial of Afatinib in Patients With EGFR-Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A This study enrolled 40 patients with mLGG ...

An innovative oral therapy represents the first major treatment advancement for low-grade gliomas in nearly 25 years. Ongoing ...

2022 NOV 28 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- New study results on gliomas have been published. According to news originating from Charlottesville, United ...

Pediatric gliomas are also known as childhood gliomas. They’re a type of tumor that can develop in a child’s central nervous system (CNS), including their brain or spinal cord. Gliomas are tumors that ...

There are no evidence-based guidelines to direct the treatment of patients with low-grade glioma, and it remains unclear whether early treatment has an impact on outcome. To compare the long-term ...

If your child has been diagnosed with a pediatric low-grade glioma (pLGG), you may be wondering where, exactly, you should go for medical care. For starters, you’ll want to look for a treatment center ...

The emergence of vorasidenib, the first targeted therapy for certain gliomas with IDH mutations, has ignited a wave of excitement in both patient and physician spaces. But following the approval, some ...

JCO Precision Oncology Conversations features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they ...